Phase IV Pilot Study of Ulipristal Acetate for Treatment of Endometriosis-related Pelvic Pain
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 10 Sep 2018
Price : $35 *
At a glance
- Drugs Ulipristal (Primary)
- Indications Endometriosis
- Focus Therapeutic Use
- 27 Sep 2016 Status changed from recruiting to active, no longer recruiting.
- 11 Feb 2015 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018 as reported by ClinicalTrials.gov record.
- 11 Feb 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.